Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.

Ishikawa, T; Dhawan, V; Chaly, T; Margouleff, C; Robeson, W; Dahl, J R; Mandel, F; Spetsieris, P; Eidelberg, D

Ishikawa, T; Dhawan, V; Chaly, T; Margouleff, C; Robeson, W; Dahl, J R; Mandel, F; Spetsieris, P; Eidelberg, D.

Affiliation

Ishikawa T; Department of Neurology, North Shore University Hospital/Cornell University Medical College, Manhasset, New York 11030, USA.

J Nucl Med ; 37(2): 216-22, 1996 Feb.

Article in En | MEDLINE | ID: mdl-8667047

Subject(s)

Corpus Striatum/enzymology; Dihydroxyphenylalanine/analogs & derivatives; Dopa Decarboxylase/metabolism; Fluorine Radioisotopes; Parkinson Disease/diagnostic imaging; Parkinson Disease/enzymology; Tomography, Emission-Computed/methods; Brain/diagnostic imaging; Brain/enzymology; Case-Control Studies; Dihydroxyphenylalanine/pharmacokinetics; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Models, Biological

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Fluorine Radioisotopes / Dihydroxyphenylalanine / Tomography, Emission-Computed / Corpus Striatum / Dopa Decarboxylase Type of study: Observational_studies / Screening_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: J Nucl Med Year: 1996 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links